Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Milestone Pharmaceuticals Inc. (NASDAQ: MIST)
MIST Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
281.70%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
400%
MIST Stock Analysis
MIST
PE Ratio:
MIST
PEG Ratio:
Not Available
MIST
Forward EPS Growth (12 month):
0.00%
MIST
PS Ratio:
61.1
MIST
PSG Ratio:
0.2
MIST
Forward Revenue Growth (12 month):
352.30%
MIST Articles
No data was found